Chapter 2 CXCR4 and Mobilization of Hematopoietic Precursors

Methods in Enzymology

Volumn 460, Issue A, 2009, Pages 57-90

  Rettig, Michael P ^a   Ramirez, Pablo ^a   Nervi, Bruno ^a   DiPersio, John F ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR CXCR4; CTCE 0021; CTCE 0214; FUCOIDIN; GRANULOCYTE COLONY STIMULATING FACTOR; PEPTIDE; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1BETA; T 134; T 140; UNCLASSIFIED DRUG; HETEROCYCLIC COMPOUND; STROMAL CELL DERIVED FACTOR 1;

ALLOTRANSPLANTATION; BLOOD; BONE MARROW; CD34 SELECTION; CELL DIFFERENTIATION; CELL MIGRATION; CELL SELECTION; CELL SURFACE; CONTINUOUS INFUSION; DONOR SELECTION; DRUG MEGADOSE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KINETICS; LEUKOCYTOSIS; LIGAND BINDING; LYMPHOCYTE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECOMMENDED DRUG DOSE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; ANIMAL; ARTICLE; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE;

MURINAE;

ANIMALS; CHEMOKINE CXCL12; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; HUMANS; MICE; PROTEIN BINDING; RECEPTORS, CXCR4;

EID: 65549129122     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05203-3     Document Type: Review

References (154)

1. Abraham M., Biyder K., Begin M., Wald H., Weiss I.D., Galun E., Nagler A., and Peled A. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003. Stem Cells 25 (2007) 2158-2166
2. Adams G.B., and Scadden D.T. The hematopoietic stem cell in its place. Nat. Immunol. 7 (2006) 333-337
3. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., Arenzana-Seisdedos F., Thelen M., and Bachelerie F. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280 (2005) 35760-35766
4. Balabanian K., Lagane B., Pablos J.L., Laurent L., Planchenault T., Verola O., Lebbe C., Kerob D., Dupuy A., Hermine O., Nicolas J.F., Latger-Cannard V., et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood 105 (2005) 2449-2457
5. Balabanian K., Levoye A., Klemm L., Lagane B., Hermine O., Harriague J., Baleux F., Arenzana-Seisdedos F., and Bachelerie F. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J. Clin. Invest. 118 (2008) 1074-1084
6. Benboubker L., Watier H., Carion A., Georget M.T., Desbois I., Colombat P., Bardos P., Binet C., and Domenech J. Association between the SDF1-3′A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br. J. Haematol. 113 (2001) 247-250
7. Bensinger W., Appelbaum F., Rowley S., Storb R., Sanders J., Lilleby K., Gooley T., Demirer T., Schiffman K., and Weaver C. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J. Clin. Oncol. 13 (1995) 2547-2555
8. Bensinger W., Dipersio J.F., and McCarty J.M. Improving stem cell mobilization strategies: Future directions. Bone Marrow Transplant 43 (2009) 181-195
9. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13 (2007) 587-596
10. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., and Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382 (1996) 829-833
11. Blom B., Ho S., Antonenko S., and Liu Y.J. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J. Exp. Med. 192 (2000) 1785-1796
12. Blom B., and Spits H. Development of human lymphoid cells. Annu. Rev. Immunol. 24 (2006) 287-320
13. Boeve S., Strupeck J., Creech S., and Stiff P.J. Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: Risk factors, cytokine use and cost. Bone Marrow Transplant. 33 (2004) 997-1003
14. Boldajipour B., Mahabaleshwar H., Kardash E., Reichman-Fried M., Blaser H., Minina S., Wilson D., Xu Q., and Raz E. Control of chemokine-guided cell migration by ligand sequestration. Cell 132 (2008) 463-473
15. Brown R.A., Adkins D., Goodnough L.T., Haug J.S., Todd G., Wehde M., Hendricks D., Ehlenbeck C., Laub L., and DiPersio J. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. J. Clin. Oncol. 15 (1997) 3067-3074
16. Broxmeyer H.E., Orschell C.M., Clapp D.W., Hangoc G., Cooper S., Plett P.A., Liles W.C., Li X., Graham-Evans B., Campbell T.B., Calandra G., Bridger G., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201 (2005) 1307-1318
17. Broxmeyer H.E., Srour E., Orschell C., Ingram D.A., Cooper S., Plett P.A., Mead L.E., and Yoder M.C. Cord blood stem and progenitor cells. Methods Enzymol. 419 (2006) 439-473
18. Bryder D., Sasaki Y., Borge O.J., and Jacobsen S.E. Deceptive multilineage reconstitution analysis of mice transplanted with hemopoietic stem cells, and implications for assessment of stem cell numbers and lineage potentials. J. Immunol. 172 (2004) 1548-1552
19. Burger J.A., and Peled A. CXCR4 antagonists: Targeting the microenvironment in leukemia and other cancers. Leukemia 23 (2009) 43-52
20. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., Penfold M.E., Sunshine M.J., Littman D.R., Kuo C.J., Wei K., McMaster B.E., et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203 (2006) 2201-2213
21. Busillo J.M., and Benovic J.L. Regulation of CXCR4 signaling. Biochim. Biophys. Acta 1768 (2007) 952-963
22. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., Martin R.P., Schipani E., Divieti P., Bringhurst F.R., Milner L.A., Kronenberg H.M., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
23. Cashman J., Bockhold K., Hogge D.E., Eaves A.C., and Eaves C.J. Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haemopoietic cells in NOD/SCID mice transplanted with human cord blood. Br. J. Haematol. 98 (1997) 1026-1036
24. Christopher M.J., Liu F., Hilton M.J., Long F., and Link D.C. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood (2009) doi: 10.1182/blood-2008-10-184754
25. Coulombel L. Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays. Oncogene 23 (2004) 7210-7222
26. Dar A., Goichberg P., Shinder V., Kalinkovich A., Kollet O., Netzer N., Margalit R., Zsak M., Nagler A., Hardan I., Resnick I., Rot A., et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat. Immunol. 6 (2005) 1038-1046
27. de Haan G., Ausema A., Wilkens M., Molineux G., and Dontje B. Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony-stimulating factor in mouse strains with distinct marrow-cell pool sizes. Br. J. Haematol. 110 (2000) 638-646
28. de Haan G., Bystrykh L.V., Weersing E., Dontje B., Geiger H., Ivanova N., Lemischka I.R., Vellenga E., and Van Zant G. A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood 100 (2002) 2056-2062
29. Devine S.M., Vij R., Rettig M., Todt L., McGlauchlen K., Fisher N., Devine H., Link D.C., Calandra G., Bridger G., Westervelt P., and Dipersio J.F. Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood 112 (2008) 990-998
30. Dlubek D., Drabczak-Skrzypek D., and Lange A. Low CXCR4 membrane expression on CD34(+) cells characterizes cells mobilized to blood. Bone Marrow Transplant. 37 (2006) 19-23
31. Eaves C., Glimm H., Eisterer W., Audet J., Maguer-Satta V., and Piret J. Characterization of human hematopoietic cells with short-lived in vivo repopulating activity. Ann. N. Y. Acad. Sci. 938 (2001) 63-70 discussion 70-71
32. Ema H., Morita Y., Yamazaki S., Matsubara A., Seita J., Tadokoro Y., Kondo H., Takano H., and Nakauchi H. Adult mouse hematopoietic stem cells: Purification and single-cell assays. Nat. Protoc. 1 (2006) 2979-2987
33. Faber A., Roderburg C., Wein F., Saffrich R., Seckinger A., Horsch K., Diehlmann A., Wong D., Bridger G., Eckstein V., Ho A.D., and Wagner W. The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells. J. Biomed. Biotechnol. 2007 (2007) 260-265
34. Feng Y., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996) 872-877
35. Forster R., Kremmer E., Schubel A., Breitfeld D., Kleinschmidt A., Nerl C., Bernhardt G., and Lipp M. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: Rapid internalization and recycling upon activation. J. Immunol. 160 (1998) 1522-1531
36. Fredriksson R., Lagerstrom M.C., Lundin L.G., and Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63 (2003) 1256-1272
37. Freud A.G., Becknell B., Roychowdhury S., Mao H.C., Ferketich A.K., Nuovo G.J., Hughes T.L., Marburger T.B., Sung J., Baiocchi R.A., Guimond M., and Caligiuri M.A. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22 (2005) 295-304
38. Fruehauf S., Seeger T., Maier P., Li L., Weinhardt S., Laufs S., Wagner W., Eckstein V., Bridger G., Calandra G., Wenz F., Zeller W.J., et al. The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics. Exp. Hematol. 34 (2006) 1052-1059
39. Fukuda S., Bian H., King A.G., and Pelus L.M. The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 110 (2007) 860-869
40. Fukuda S., and Pelus L.M. Transmigration of human CD34+ cells. Methods Mol. Biol. 430 (2008) 55-75
41. Gandhi M.K., Jestice K., Scott M.A., Bloxham D., Bass G., and Marcus R.E. The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplant. 23 (1999) 9-13
42. Gazitt Y., Freytes C.O., Callander N., Tsai T.W., Alsina M., Anderson J., Holle L., Cruz J., Devore P., McGrath M., West G., Alvarez R., et al. Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization. J. Hematother. 8 (1999) 173-183
43. Giebel B., and Punzel M. Lineage development of hematopoietic stem and progenitor cells. Biol. Chem. 389 (2008) 813-824
44. Glimm H., Eisterer W., Lee K., Cashman J., Holyoake T.L., Nicolini F., Shultz L.D., von Kalle C., and Eaves C.J. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J. Clin. Invest. 107 (2001) 199-206
45. Gorlin R.J., Gelb B., Diaz G.A., Lofsness K.G., Pittelkow M.R., and Fenyk Jr. J.R. WHIM syndrome, an autosomal dominant disorder: Clinical, hematological, and molecular studies. Am. J. Med. Genet. 91 (2000) 368-376
46. Grande F., Garofalo A., and Neamati N. Small molecules anti-HIV therapeutics targeting CXCR4. Curr. Pharm. Des. 14 (2008) 385-404
47. Group S.C.T.C. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials. J. Clin Oncol. 23 (2005) 5074-5087
48. Gulino A.V. WHIM syndrome: A genetic disorder of leukocyte trafficking. Curr. Opin. Allergy Clin. Immunol. 3 (2003) 443-450
49. Gulino A.V., Moratto D., Sozzani S., Cavadini P., Otero K., Tassone L., Imberti L., Pirovano S., Notarangelo L.D., Soresina R., Mazzolari E., Nelson D.L., et al. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood 104 (2004) 444-452
50. Haribabu B., Richardson R.M., Fisher I., Sozzani S., Peiper S.C., Horuk R., Ali H., and Snyderman R. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J. Biol. Chem. 272 (1997) 28726-28731
51. Harrison D.E. Competitive repopulation: A new assay for long-term stem cell functional capacity. Blood 55 (1980) 77-81
52. Harrison D.E., Jordan C.T., Zhong R.K., and Astle C.M. Primitive hemopoietic stem cells: Direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp. Hematol. 21 (1993) 206-219
53. Hartmann T.N., Grabovsky V., Pasvolsky R., Shulman Z., Buss E.C., Spiegel A., Nagler A., Lapidot T., Thelen M., and Alon R. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J. Leukoc. Biol. 84 (2008) 1130-1140
54. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., Hackett N.R., Quitoriano M.S., Crystal R.G., Rafii S., and Moore M.A. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97 (2001) 3354-3360
55. Hawley R.G., Ramezani A., and Hawley T.S. Hematopoietic stem cells. Methods Enzymol. 419 (2006) 149-179
56. Henon P.R., Liang H., Beck-Wirth G., Eisenmann J.C., Lepers M., Wunder E., and Kandel G. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant. 9 (1992) 285-291
57. Herbert K.E., Levesque J.P., Haylock D.N., and Prince H.M. The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilization. Biol. Blood Marrow Transplant. 14 (2008) 603-621
58. Hernandez J.M., Castilla C., Gutierrez N.C., Isidro I.M., Delgado M., de las Rivas J., Ferminan E., Garcia J.L., Ocio E.M., del Canizo M.C., and San Miguel J.F. Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes. Leukemia 19 (2005) 1088-1091
59. Hernandez P.A., Gorlin R.J., Lukens J.N., Taniuchi S., Bohinjec J., Francois F., Klotman M.E., and Diaz G.A. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 34 (2003) 70-74
60. Hess D.A., Bonde J., Craft T.P., Wirthlin L., Hohm S., Lahey R., Todt L.M., Dipersio J.F., Devine S.M., and Nolta J.A. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biol. Blood Marrow Transplant. 13 (2007) 398-411
61. Hill G.R., Morris E.S., Fuery M., Hutchins C., Butler J., Grigg A., Roberts A., Bradstock K., Szer J., Kennedy G., Morton J., and Durrant S. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF. Biol. Blood Marrow Transplant. 12 (2006) 603-607
62. Hubel K., Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Cooper S., Hangoc G., Macfarland R., Bridger G.J., Henson G.W., Calandra G., and Dale D.C. Leukocytosis and mobilization of CD34+ hematopoietic progenitor cells by AMD3100, a CXCR4 antagonist. Support Cancer Ther. 1 (2004) 165-172
63. Imai K., Kobayashi M., Wang J., Shinobu N., Yoshida H., Hamada J., Shindo M., Higashino F., Tanaka J., Asaka M., and Hosokawa M. Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: A possible role in homing of haemopoietic progenitor cells to bone marrow. Br. J. Haematol. 106 (1999) 905-911
64. Ito M., Hiramatsu H., Kobayashi K., Suzue K., Kawahata M., Hioki K., Ueyama Y., Koyanagi Y., Sugamura K., Tsuji K., Heike T., and Nakahata T. NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 100 (2002) 3175-3182
65. Iyer C.V., Evans R.J., Lou Q., Lin D., Wang J., Kohn W., Yan L.Z., Pulley S., and Peng S.B. Rapid and recurrent neutrophil mobilization regulated by T134, a CXCR4 peptide antagonist. Exp. Hematol. 36 (2008) 1098-1109
66. Jin P., Wang E., Ren J., Childs R., Shin J.W., Khuu H., Marincola F.M., and Stroncek D.F. Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis. J. Translational Med. 6 (2008) 39
67. Jung Y., Wang J., Schneider A., Sun Y.X., Koh-Paige A.J., Osman N.I., McCauley L.K., and Taichman R.S. Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 38 (2006) 497-508
68. Katayama Y., Battista M., Kao W.M., Hidalgo A., Peired A.J., Thomas S.A., and Frenette P.S. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124 (2006) 407-421
69. Kawai T., Choi U., Cardwell L., DeRavin S.S., Naumann N., Whiting-Theobald N.L., Linton G.F., Moon J., Murphy P.M., and Malech H.L. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4. Blood 109 (2007) 78-84
70. Kawai T., Choi U., Whiting-Theobald N.L., Linton G.F., Brenner S., Sechler J.M., Murphy P.M., and Malech H.L. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome. Exp. Hematol. 33 (2005) 460-468
71. Khan A., Greenman J., and Archibald S.J. Small molecule CXCR4 chemokine receptor antagonists: Developing drug candidates. Curr. Med. Chem. 14 (2007) 2257-2277
72. Kiel M.J., and Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol. 8 (2008) 290-301
73. Kiel M.J., Yilmaz O.H., Iwashita T., Terhorst C., and Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
74. Kiger A.A., White-Cooper H., and Fuller M.T. Somatic support cells restrict germline stem cell self-renewal and promote differentiation. Nature 407 (2000) 750-754
75. Kobbe G., Sohngen D., Bauser U., Schneider P., Germing U., Thiele K.P., Rieth C., Hunerliturkoglu A., Fischer J., Frick M., Wernet P., Aul C., et al. Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma. Ann. Hematol. 78 (1999) 456-462
76. Kollet O., Dar A., and Lapidot T. The multiple roles of osteoclasts in host defense: Bone remodeling and hematopoietic stem cell mobilization. Annu. Rev. Immunol. 25 (2007) 51-69
77. Kollet O., Peled A., Byk T., Ben-Hur H., Greiner D., Shultz L., and Lapidot T. beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95 (2000) 3102-3105
78. Kollet O., Spiegel A., Peled A., Petit I., Byk T., Hershkoviz R., Guetta E., Barkai G., Nagler A., and Lapidot T. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood 97 (2001) 3283-3291
79. Kroschinsky F., Holig K., and Ehninger G. The role of pegfilgrastim in mobilization of hematopoietic stem cells. Transfus. Apheresis Sci. 38 (2008) 237-244
80. Kroschinsky F., Holig K., Poppe-Thiede K., Zimmer K., Ordemann R., Blechschmidt M., Oelschlaegel U., Bornhauser M., Rall G., Rutt C., and Ehninger G. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors. Haematologica 90 (2005) 1665-1671
81. Kucia M., Jankowski K., Reca R., Wysoczynski M., Bandura L., Allendorf D.J., Zhang J., Ratajczak J., and Ratajczak M.Z. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 35 (2004) 233-245
82. Lane T.A., Law P., Maruyama M., Young D., Burgess J., Mullen M., Mealiffe M., Terstappen L.W., Hardwick A., and Moubayed M. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85 (1995) 275-282
83. Lapidot T., Dar A., and Kollet O. How do stem cells find their way home?. Blood 106 (2005) 1901-1910
84. Larochelle A., Vormoor J., Hanenberg H., Wang J.C., Bhatia M., Lapidot T., Moritz T., Murdoch B., Xiao X.L., Kato I., Williams D.A., and Dick J.E. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat. Med. 2 (1996) 1329-1337
85. Lemieux M.E., Rebel V.I., Lansdorp P.M., and Eaves C.J. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow "switch" cultures. Blood 86 (1995) 1339-1347
86. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., and Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111 (2003) 187-196
87. Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Hubel K., Cooper S., Hangoc G., Bridger G.J., Henson G.W., Calandra G., and Dale D.C. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102 (2003) 2728-2730
88. Lin K.K., and Goodell M.A. Purification of hematopoietic stem cells using the side population. Methods Enzymol. 420 (2006) 255-264
89. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., and Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269 (1994) 232-237
90. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., Bronson R.T., and Springer T.A. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95 (1998) 9448-9453
91. Ma Q., Jones D., and Springer T.A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10 (1999) 463-471
92. Marchese A., Paing M.M., Temple B.R., and Trejo J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 601-629
93. McKenzie J.L., Gan O.I., Doedens M., and Dick J.E. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood 106 (2005) 1259-1261
94. Miller C.L., Dykstra B., and Eaves C.J. Characterization of mouse hematopoietic stem and progenitor cells. Curr. Protoc. Immunol. 22 (2008) Unit 22B 2
95. Molineux G., Pojda Z., and Dexter T.M. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 75 (1990) 563-569
96. Montgomery M., and Cottler-Fox M. Mobilization and collection of autologous hematopoietic progenitor/stem cells. Clin. Adv. Hematol. Oncol. 5 (2007) 127-136
97. MOZOBIL. Plerixafor Injection. (Package insert) (2008), Genzyme Corporation
98. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., and Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382 (1996) 635-638
99. Nagler A., Korenstein-Ilan A., Amiel A., and Avivi L. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp. Hematol. 32 (2004) 122-130
100. Nervi B., Link D.C., and DiPersio J.F. Cytokines and hematopoietic stem cell mobilization. J. Cell Biochem. 99 (2006) 690-705
101. Nervi B., Ramirez P., Rettig M.P., Uy G.L., Holt M.S., Ritchey J.K., Prior J.L., Piwnica-Worms D., Bridger G., Ley T.J., and Dipersio J.F. Chemosensitization of AML following mobilization by the CXCR4 antagonist AMD3100. Blood (2008) doi: 10.1182/blood-2008-06-162123
102. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382 (1996) 833-835
103. Oelschlaegel U., Bornhauser M., Boxberger S., Kroschinsky F., Illmer T., Hoelig K., Calandra G., Ehninger G., and Platzbecker U. Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma. Ann. Hematol. 86 (2007) 569-573
104. Orsini M.J., Parent J.L., Mundell S.J., Marchese A., and Benovic J.L. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the C-terminal tail that mediate receptor internalization. J. Biol. Chem. 274 (1999) 31076-31086
105. Papayannopoulou T., and Scadden D.T. Stem-cell ecology and stem cells in motion. Blood 111 (2008) 3923-3930
106. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben-Hur H., Many A., Shultz L., Lider O., Alon R., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
107. Pelus L.M. Peripheral blood stem cell mobilization: New regimens, new cells, where do we stand. Curr. Opin. Hematol. 15 (2008) 285-292
108. Pelus L.M., Bian H., Fukuda S., Wong D., Merzouk A., and Salari H. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Exp. Hematol. 33 (2005) 295-307
109. Pelus L.M., and Fukuda S. Chemokine-mobilized adult stem cells: Defining a better hematopoietic graft. Leukemia 22 (2008) 466-473
110. Pflumio F., Izac B., Katz A., Shultz L.D., Vainchenker W., and Coulombel L. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88 (1996) 3731-3740
111. Ponomaryov T., Peled A., Petit I., Taichman R.S., Habler L., Sandbank J., Arenzana-Seisdedos F., Magerus A., Caruz A., Fujii N., Nagler A., Lahav M., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest. 106 (2000) 1331-1339
112. Purton L.E., and Scadden D.T. Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell 1 (2007) 263-270
113. Pusic I., Jiang S.Y., Landua S., Uy G.L., Rettig M.P., Cashen A.F., Westervelt P., Vij R., Abboud C.N., Stockerl-Goldstein K.E., Sempek D.S., Smith A.L., et al. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol. Blood Marrow Transplant. 14 (2008) 1045-1056
114. Ramirez P.A., Rettig M., Holt M., Ritchey J.K., and DiPersio J.F. Rapid mobilization of long term repopulating hematopoietic stem cells (HSC) with AMD15057, a small molecule inhibitor of VLA4; synergism with AMD3100 and G-CSF. Blood 112 (2008) 229 615a
115. Rettig M.P., Shannon W.D., Ritchey J., Holt M., McFarland K., Lopez S., Gabriel J., and DiPersio J.F. Characterization of human CD34+ hematopoietic stem cells following administration of G-CSF or plerixafor. Blood 112 (2008) 1192 3476a
116. Roberts A.W., Foote S., Alexander W.S., Scott C., Robb L., and Metcalf D. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 89 (1997) 2736-2744
117. Robinson S.N., and van Os R.P. Mobilization of hematopoietic stem and progenitor cells in mice. Methods Mol. Biol. 430 (2008) 31-53
118. Schmitz N., Linch D.C., Dreger P., Goldstone A.H., Boogaerts M.A., Ferrant A., Demuynck H.M., Link H., Zander A., and Barge A. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347 (1996) 353-357
119. Semerad C.L., Christopher M.J., Liu F., Short B., Simmons P.J., Winkler I., Levesque J.P., Chappel J., Ross F.P., and Link D.C. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106 (2005) 3020-3027
120. Shalekoff S., and Tiemessen C.T. Duration of sample storage dramatically alters expression of the human immunodeficiency virus coreceptors CXCR4 and CCR5. Clin. Diagn. Lab. Immunol. 8 (2001) 432-436
121. Shapira M.Y., Kaspler P., Samuel S., Shoshan S., and Or R. Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors. Am. J. Hematol. 73 (2003) 33-36
122. Shen H., Cheng T., Olszak I., Garcia-Zepeda E., Lu Z., Herrmann S., Fallon R., Luster A.D., and Scadden D.T. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J. Immunol. 166 (2001) 5027-5033
123. Sheridan W.P., Begley C.G., To L.B., Grigg A., Szer J., Maher D., Green M.D., Rowlings P.A., McGrath K.M., and Cebon J. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant. 14 (1994) 105-111
124. Shultz L.D., Lyons B.L., Burzenski L.M., Gott B., Chen X., Chaleff S., Kotb M., Gillies S.D., King M., Mangada J., Greiner D.L., and Handgretinger R. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174 (2005) 6477-6489
125. Sierro F., Biben C., Martinez-Munoz L., Mellado M., Ransohoff R.M., Li M., Woehl B., Leung H., Groom J., Batten M., Harvey R.P., Martinez A.C., et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 104 (2007) 14759-14764
126. Signoret N., Oldridge J., Pelchen-Matthews A., Klasse P.J., Tran T., Brass L.F., Rosenkilde M.M., Schwartz T.W., Holmes W., Dallas W., Luther M.A., Wells T.N., et al. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell Biol. 139 (1997) 651-664
127. Signoret N., Rosenkilde M.M., Klasse P.J., Schwartz T.W., Malim M.H., Hoxie J.A., and Marsh M. Differential regulation of CXCR4 and CCR5 endocytosis. J. Cell Sci. 111 Pt 18 (1998) 2819-2830
128. Sugiyama T., Kohara H., Noda M., and Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25 (2006) 977-988
129. Sutherland H.J., Eaves C.J., Eaves A.C., Dragowska W., and Lansdorp P.M. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74 (1989) 1563-1570
130. Sutherland H.J., Eaves C.J., Lansdorp P.M., Thacker J.D., and Hogge D.E. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78 (1991) 666-672
131. Sweeney E.A., Lortat-Jacob H., Priestley G.V., Nakamoto B., and Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: Involvement in mobilization of stem/progenitor cells. Blood 99 (2002) 44-51
132. Szilvassy S.J., Humphries R.K., Lansdorp P.M., Eaves A.C., and Eaves C.J. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc. Natl. Acad. Sci. USA 87 (1990) 8736-8740
133. Szilvassy S.J., Lansdorp P.M., Humphries R.K., Eaves A.C., and Eaves C.J. Isolation in a single step of a highly enriched murine hematopoietic stem cell population with competitive long-term repopulating ability. Blood 74 (1989) 930-939
134. Tachibana K., Hirota S., Iizasa H., Yoshida H., Kawabata K., Kataoka Y., Kitamura Y., Matsushima K., Yoshida N., Nishikawa S., Kishimoto T., and Nagasawa T. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393 (1998) 591-594
135. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126 (1981) 1614-1619
136. Tigue C.C., McKoy J.M., Evens A.M., Trifilio S.M., Tallman M.S., and Bennett C.L. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: An overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 40 (2007) 185-192
137. Tricot G., Jagannath S., Vesole D., Nelson J., Tindle S., Miller L., Cheson B., Crowley J., and Barlogie B. Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85 (1995) 588-596
138. Uy G.L., Rettig M.P., and Cashen A.F. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert Opin. Biol. Ther. 8 (2008) 1797-1804
139. van Os R.P., Dethmers-Ausema B., and de Haan G. In vitro assays for cobblestone area-forming cells, LTC-IC, and CFU-C. Methods Mol. Biol. 430 (2008) 143-157
140. Voermans C., Kooi M.L., Rodenhuis S., van der Lelie H., van der Schoot C.E., and Gerritsen W.R. In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation. Blood 97 (2001) 799-804
141. Wang S., Nademanee A., Qian D., Dagis A., Park H.S., Fridey J., Smith E., Snyder D., Somlo G., Stein A., Rosenthal J., Falk P., et al. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation. Transfusion 47 (2007) 2207-2216
142. Watt S.M., and Forde S.P. The central role of the chemokine receptor, CXCR4, in haemopoietic stem cell transplantation: Will CXCR4 antagonists contribute to the treatment of blood disorders?. Vox Sang 94 (2008) 18-32
143. Weaver C.H., Hazelton B., Birch R., Palmer P., Allen C., Schwartzberg L., and West W. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86 (1995) 3961-3969
144. Weissman I.L., and Shizuru J.A. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 112 (2008) 3543-3553
145. Wilson A., and Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 6 (2006) 93-106
146. Winkler I.G., and Levesque J.P. Mechanisms of hematopoietic stem cell mobilization: When innate immunity assails the cells that make blood and bone. Exp. Hematol. 34 (2006) 996-1009
147. Xie T., and Spradling A.C. A niche maintaining germ line stem cells in the Drosophila ovary. Science 290 (2000) 328-330
148. Yang O.O., Swanberg S.L., Lu Z., Dziejman M., McCoy J., Luster A.D., Walker B.D., and Herrmann S.H. Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4. J. Virol. 73 (1999) 4582-4589
149. Yuan R., Astle C.M., Chen J., and Harrison D.E. Genetic regulation of hematopoietic stem cell exhaustion during development and growth. Exp. Hematol. 33 (2005) 243-250
150. Zamboni W.C. Pharmacokinetics of pegfilgrastim. Pharmacotherapy 23 (2003) 9S-14S
151. Zeller W., Gutensohn K., Stockschlader M., Dierlamm J., Kroger N., Koehne G., Hummel K., Kabisch H., Weh H.J., Kuhnl P., Hossfeld D.K., and Zander A.R. Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. Bone Marrow Transplant. 17 (1996) 709-713
152. Zhang Y., Foudi A., Geay J.F., Berthebaud M., Buet D., Jarrier P., Jalil A., Vainchenker W., and Louache F. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells 22 (2004) 1015-1029
153. Zhong R., Law P., Wong D., Merzouk A., Salari H., and Ball E.D. Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells. Exp. Hematol. 32 (2004) 470-475
154. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., and Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393 (1998) 595-599